Holland exits Mauritskliniek in sale to PE-backed Corius
Holland Capital has sold Dutch dermatology platform Mauritskliniek to Ufenau-backed Corius, nine months after an exit to Triton-owned Bergman was blocked by the competition authorities.
More on Benelux
Golding aims to raise EUR 350m for next buyout co-investment fund amid ‘unprecedented’ dealflow
Vehicle expects to make its first deals this year, providing additional equity for deals against a tough fundraising backdrop
The Bolt-Ons Digest - 26 May 2023
Unquote’s selection of the latest add-ons with H&F's TeamSystem, Nordic Capital's Regnology, 3'i's Dutch Bakery and more
Q1 Barometer: Signs of a brighter future after dark times for European PE
The latest Unquote Private Equity Barometer, produced in association with abrdn, is now available to download
Bregal Milestone closes second tech fund on EUR 770m
European technology investor has around 60% dry powder remaining to deploy in its latest fund
Latest News
Golding aims to raise EUR 350m for next buyout co-investment fund amid ‘unprecedented’ dealflow
Vehicle expects to make its first deals this year, providing additional equity for deals against a tough fundraising backdrop
Permira to acquire majority stake in Gruppo Florence
Existing shareholders including VAM Investments and management of the Italian fashion group will reinvest, while Italmobiliare will exit
Mimir Group ramps up global origination effort with London office and focus on life science carve-outs
Stockholm-based investor is considering divestments, although challenging market remains a barrier
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt